species reactivity
human
Quality Level
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
assay range
accuracy: 84-108%, standard curve range: 14-10,000 pg/mL
(S100B), standard curve range: 21-15,000 pg/mL
(sRAGE), standard curve range: 27-20,000 pg/mL
(Amyloid β42), standard curve range: 3-2,500 pg/mL
(Amyloid β40), standard curve range: 7-5,000 pg/mL
(GDNF)
technique(s)
multiplexing: suitable
input
cerebrospinal fluid(s) (CSF)
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
正在寻找类似产品? 访问 产品对比指南
General description
Application
Analytes included: S100B, Amyloid β40 (Aβ40), Amyloid β42 (Aβ42), sRAGE, GDNF.
Note: Serum and plasma are not verified sample types for this assay.
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Comprehensive Alzheimer′s Pathway Coverage: Simultaneously quantify amyloid-beta peptides, S100B neuroinflammation marker, sRAGE receptor, and GDNF neuroprotective factor, providing complete insight into key Alzheimer′s disease mechanisms in one assay.
- CSF-Optimized Excellence: Specifically verified for cerebrospinal fluid analysis with exceptional spike recovery (84-108%), ensuring accurate quantification of these critical brain-derived biomarkers in precious CSF samples.
- Streamlined Neuroscience Discovery: Eliminate the complexity of five separate assays with our integrated multiplex format, accelerating your Alzheimer′s research while maximizing the utility of limited CSF samples for comprehensive biomarker profiling.
- Target Discovery Power: Leverage biomarkers spanning amyloid aggregation, neuroinflammation, and neuroprotection pathways to identify therapeutic interventions targets.
- Precision-Engineered Reliability: Trust in < 10% intra-assay precision across all analytes and < 15% inter-assay variability, delivering the data consistency essential for breakthrough neurodegenerative research.
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Skin Sens. 1
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
法规信息
相关内容
Learn how multiplex detection of Alzheimer’s disease biomarkers, using the MILLIPLEX® Human Amyloid Beta and Tau Magnetic Bead Panel, allows for a different perspective on neurodegenerative disease research.
Neuroscience multiplex assays, such as MILLIPLEX® multiplex assays, enable simultaneous measurement of neuroscience-related biomarkers to gain a better picture of neurodegenerative diseases, neurological disorders, and neuropeptide/neurohormone signaling.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持